Skip to content

To study management of chaturjatak vati in hyperlipidemia

A single arm clinical study to evaluate the efficacy of chaturjataka vati in the management of hyperlipidemia - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/05/067526
Enrollment
35
Registered
2024-05-17
Start date
Unknown
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E785- Hyperlipidemia, unspecified

Interventions

None listed

Sponsors

Dr. Amey Rajendra Ekhande
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Age limit from 30 to 70 yrs. 2) Newly detected Hyperlipidemic or known case of Hyperlipidemic patients.

Exclusion criteria

Exclusion criteria: 1) Pregnant women & lactating mothers. 2) Patient with severe renal, hepatic, coronary heart diseases.

Design outcomes

Primary

MeasureTime frame
To reduce LDL, Total cholesterol, Triglycerides and Increase HDL levelsTimepoint: 60 days study. 20th, 40th, 60th follow up days

Secondary

MeasureTime frame
1) To study present day food habits and lifestyle as a causative factor for Hyperlipidemia. 2) To study the concept and role of Agnideepana and Amapachana in the management of hyperlipidemia.Timepoint: 60 days study. 20th, 40th, 60th follow up days

Countries

India

Contacts

Public ContactDr Gunvant Yeola

Dr. D. Y. Patil college of Ayurveda and Research center

Gunvantayurved@gmail.com9028321955

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026